These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14250860)

  • 21. [Sulfonylurea derivatives in the treatment of some parenchymal lesions of the liver].
    DOBRZANSKI T
    Pol Arch Med Wewn; 1962; 32():901-6. PubMed ID: 14028259
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypoglycemic compounds. Amino acid derivatives of sulfonylurea. II.
    Vicentini CB; Guarneri M; Sarto G
    Farmaco Sci; 1983 Sep; 38(9):672-8. PubMed ID: 6641933
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of sulfonylurea derivatives on the course of acute viral hepatitis].
    LASZLO B; BRUCKNER P
    Orv Hetil; 1961 Jul; 102():1405-10. PubMed ID: 13759341
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy and hazards of an experimental hypoglycemic sulfonylurea compound: metahexamide].
    VERNET A; RILLIET B
    Praxis; 1960 Jun; 49():620-3. PubMed ID: 13841881
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the effects of sulfonylurea derivatives on the course of acute viral hepatitis].
    LASZLO B; BRUCKNER P
    Munch Med Wochenschr; 1962 Feb; 104():226-34. PubMed ID: 14462647
    [No Abstract]   [Full Text] [Related]  

  • 26. ["Diabetic states" in pregnancy and their treatment with sulfonylurea derivatives. (Preliminary note)].
    LOPEZ-FERNANDIZ JR
    Hisp Med; 1960 Sep; 17():423-9. PubMed ID: 13763473
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral hypoglycemic agents past and present other than sulfonylurea compounds.
    GOLDNER MG
    AMA Arch Intern Med; 1958 Nov; 102(5):830-40. PubMed ID: 13582273
    [No Abstract]   [Full Text] [Related]  

  • 28. [HYPOGLYCEMIC EFFECT OF SULFONYLUREAS (BZ-55,D-860) IN ANIMALS WITH INTERRUPTED CIRCULATION IN THE SPLANCHNIC AREA].
    MOSINGER B; KUJALOVA V; WENKEOVA J
    Cesk Gastroenterol Vyz; 1963 Jan; 17():32-6. PubMed ID: 14053006
    [No Abstract]   [Full Text] [Related]  

  • 29. [Oral antidiabetics of the sulfonylurea group and their problems in therapy].
    Füsgen I; Summa JD
    Z Gerontol; 1980; 13(1):45-51. PubMed ID: 7456613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New compounds and reactions of sulfonamides with amines. XV. Synthesis and hypoglycemic activity of some derivatives of N-(benzenesulfonyl)-3,5-diethyl-5-methyl-2-pyrazoline-1-carbonamide].
    Brzozowski Z; Dekarz B; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1976; 33(3):301-5. PubMed ID: 941694
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and hypoglycemic activity of trifluoromethylated sulphonylureas.
    PERRON YG; PINDELL MH; CRAST LB; CHENEY LC
    J Med Pharm Chem; 1961 Jul; 4():41-9. PubMed ID: 14485539
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative effect of various hypoglycemic sulfonylurea compounds on thyroid function in the rat].
    ZIZINE L
    Ann Endocrinol (Paris); 1957; 18(4):673-5. PubMed ID: 13498450
    [No Abstract]   [Full Text] [Related]  

  • 33. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 34. [Views on the mechanism of action of sulfonylurea compounds].
    STERKOWICZ S
    Pol Tyg Lek; 1960 May; 15():803-6. PubMed ID: 13834409
    [No Abstract]   [Full Text] [Related]  

  • 35. [The chemotherapeutic use of antidiabetics. Sulfonylurea compounds and glinides].
    Mark M
    Pharm Unserer Zeit; 2002; 31(3):252-62. PubMed ID: 12071122
    [No Abstract]   [Full Text] [Related]  

  • 36. [Degradation reactions of oral antidiabetics. 2. Reaction of arylsulfonylureas with 4-toluenesulfonyl chloride].
    Egg H; Leibetseder H; Patzak A; Steinkellner L
    Arch Pharm (Weinheim); 1987 Mar; 320(3):253-7. PubMed ID: 3579526
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and antihyperglycemic evaluation of new 2,4-thiazolidinediones having biodynamic aryl sulfonylurea moieties.
    Jawale DV; Pratap UR; Rahuja N; Srivastava AK; Mane RA
    Bioorg Med Chem Lett; 2012 Jan; 22(1):436-9. PubMed ID: 22123321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [STUDIES ON NITROFURAN DERIVATIVES. I. SYNTHESIS OF 5-NITROFURFURAL N-SUBSTITUTED AMINOACYLHYDRAZONE DERIVATIVES AND RELATED COMPOUNDS].
    FUJITA A; MINAMI S; TAKAMATSU H
    Yakugaku Zasshi; 1964 Sep; 84():890-3. PubMed ID: 14247821
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug information. Agents for the treatment of diabetes mellitus (antidiabetics). Therapeutic maon group: oral antidiabetics].
    Lumholtz IB
    Sygeplejersken; 1977 Aug; 77(32):15. PubMed ID: 242378
    [No Abstract]   [Full Text] [Related]  

  • 40. [Degradation reactions of oral antidiabetics. 3. On the reactions of arylsulfonylureas with carbodiimides].
    Egg H; Gnauer U; Hambrusch B
    Arch Pharm (Weinheim); 1987 Aug; 320(8):673-6. PubMed ID: 3675162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.